A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Clinical trial NCT01143246 · COMPLETED
Trial details
- NCT number
- NCT01143246
- Sponsor
- Mallinckrodt
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-11
- Primary completion
- 2013-02-01
- Enrollment
- 196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.